2677 — Distinct Healthcare Holdings Cashflow Statement
0.000.00%
- HK$1.56bn
- HK$4.50bn
- CNY1.06bn
Annual cashflow statement for Distinct Healthcare Holdings, fiscal year end - December 31st, millions except per share.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | |
| Standards: | — | IFRS | IFRS | IFRS |
| Status: | fx Preliminary | Final | Final | Final |
| Net Income/Starting Line | — | -362 | 79.7 | 136 |
| Depreciation | ||||
| Non-Cash Items | — | 11.5 | 49.5 | 22 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | — | 347 | -93.8 | -79.6 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | — | 124 | 171 | 211 |
| Capital Expenditures | — | -66.4 | -58 | -48.9 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | 64.9 | 144 | -31.5 |
| Sale of Business | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Change in Net Intangibles | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | — | -1.48 | 86 | -80.4 |
| Financing Cash Flow Items | — | -77.9 | -139 | -112 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | — | -72.4 | -150 | -112 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | — | 52 | 110 | 16.9 |